an epitope editing approach to enable the use of targeted immunotherapy in aml
Published 3 months ago • 90 plays • Length 3:12Download video MP4
Download video MP3
Similar videos
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
4:48
an insight into the management of cytopenias in mf
-
2:16
the challenges in producing efficacious i-o products for aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
13:05
elispot assayi
-
3:39
zen-3694, a novel bet inhibitor, in tnbc without germline brca1/2 mutations
-
7:50
which aml patients benefit most from venetoclax treatment?
-
2:13
haploidentical sct for the treatment of secondary aml
-
0:51
key unmet needs in the treatment of immune-mediated ttp
-
3:10
novel aml treament approaches
-
0:57
the potential of the tsafinder tool in hematological oncology
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
2:50
the impact of induction therapy on post-transplant outcomes in aml
-
1:14
highlights in quality management from ebmt
-
3:52
venetoclax & aml
-
2:01
characterizing novel t-cell epitopes of human papillomavirus l protocol preview
-
1:37
mrd in myeloma
-
1:51
thrombotic and bleeding complications in al amyloidosis